Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AxyS achieves milestone in Rhone-Poulenc Rorer collaboration

Dec. 2, 1999

First report of efficacy of an antihistamine in vasomotor rhinitis presented at ACAAI meeting

Dec. 1, 1999

rhuMAb-E25 may be safely administered during a second pollen season

Dec. 1, 1999

1999 ACAAI news: SC-236 modulates histamine release in in vitro model of allergy

Dec. 1, 1999

Dynavax and Stallergenes to develop seasonal allergy therapy

Nov. 29, 1999

Amrad to distribute PathoGenesis's inhalable CF treatment in Australia

Nov. 26, 1999

SB investigates CCR3 receptor blockade as a novel approach to allergic, inflammatory disorders

Nov. 25, 1999

Advair approved in Canada, recommended for approval in U.S.

Nov. 25, 1999

Curosurf approved in U.S. for treatment of RDS in premature infants

Nov. 25, 1999

Sepracor and Abbott to copromote Xopenex in the U.S.

Nov. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...